Literature DB >> 9000097

Persistent infection of mammalian cells by Rift Valley fever virus.

A Billecocq1, P Vialat, M Bouloy.   

Abstract

Infection of mammalian cells with Rift Valley fever virus (RVFV) leads generally to the production of virus and cell death. In this paper we examined the fate of Vero cells infected with three strains of RVFV and observed that, while a large proportion of cells exhibited a clear cytopathic effect (CPE), a small but significant fraction did not undergo a lytic infection but was able to proliferate and establish a persistent infection. Several independent RVFV persistently infected cell lines have been established and passaged for more than 1 year after infection with a virulent strain (ZH548) and two attenuated strains (C13 and MP12). Although the viruses used for the primary infection were plaque-purified, we do not know whether defective-interfering particles were responsible for the establishment of the persistent infection. The persistently infected cells became resistant to superinfection with RVFV but not with other viruses and shed low amounts of infectious, lytic and non-lytic virus during a limited number of passages. In all the passages tested, the three genomic segments or related products were synthesized as well as the structural nucleoprotein N and glycoproteins G1 and G2. Abnormal defective RNAs were detected, migrating faster or slower than their respective counterparts. The faster-migrating RNAs were internally deleted, some of them possessing only the very terminal part of the 5' genomic end.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9000097     DOI: 10.1099/0022-1317-77-12-3053

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  10 in total

1.  The S segment of rift valley fever phlebovirus (Bunyaviridae) carries determinants for attenuation and virulence in mice.

Authors:  P Vialat; A Billecocq; A Kohl; M Bouloy
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

2.  Creation of a nonspreading Rift Valley fever virus.

Authors:  Jeroen Kortekaas; Nadia Oreshkova; Viviana Cobos-Jiménez; Rianka P M Vloet; Christiaan A Potgieter; Rob J M Moormann
Journal:  J Virol       Date:  2011-09-28       Impact factor: 5.103

3.  Quantitative Proteomics of Uukuniemi Virus-host Cell Interactions Reveals GBF1 as Proviral Host Factor for Phleboviruses.

Authors:  Zina M Uckeley; Rebecca Moeller; Lars I Kühn; Emma Nilsson; Claudia Robens; Lisa Lasswitz; Richard Lindqvist; Annasara Lenman; Vania Passos; Yannik Voss; Christian Sommerauer; Martin Kampmann; Christine Goffinet; Felix Meissner; Anna K Överby; Pierre-Yves Lozach; Gisa Gerold
Journal:  Mol Cell Proteomics       Date:  2019-09-30       Impact factor: 5.911

4.  NSs protein of Rift Valley fever virus blocks interferon production by inhibiting host gene transcription.

Authors:  Agnès Billecocq; Martin Spiegel; Pierre Vialat; Alain Kohl; Friedemann Weber; Michèle Bouloy; Otto Haller
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

5.  RNA polymerase I-mediated expression of viral RNA for the rescue of infectious virulent and avirulent Rift Valley fever viruses.

Authors:  Agnès Billecocq; Nicolas Gauliard; Nicolas Le May; Richard M Elliott; Ramon Flick; Michèle Bouloy
Journal:  Virology       Date:  2008-07-09       Impact factor: 3.616

6.  Persistent baculovirus infection results from deletion of the apoptotic suppressor gene p35.

Authors:  J C Lee; H H Chen; Y C Chao
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103

7.  Host alternation is necessary to maintain the genome stability of rift valley fever virus.

Authors:  Sara Moutailler; Benjamin Roche; Jean-Michel Thiberge; Valérie Caro; François Rougeon; Anna-Bella Failloux
Journal:  PLoS Negl Trop Dis       Date:  2011-05-24

8.  NSs amyloid formation is associated with the virulence of Rift Valley fever virus in mice.

Authors:  Psylvia Léger; Eliana Nachman; Karsten Richter; Carole Tamietti; Jana Koch; Robin Burk; Susann Kummer; Qilin Xin; Megan Stanifer; Michèle Bouloy; Steeve Boulant; Hans-Georg Kräusslich; Xavier Montagutelli; Marie Flamand; Carmen Nussbaum-Krammer; Pierre-Yves Lozach
Journal:  Nat Commun       Date:  2020-07-01       Impact factor: 14.919

9.  Distinct virulence of Rift Valley fever phlebovirus strains from different genetic lineages in a mouse model.

Authors:  Tetsuro Ikegami; Aaron Balogh; Shoko Nishiyama; Nandadeva Lokugamage; Tais B Saito; John C Morrill; Vinay Shivanna; Sabarish V Indran; Lihong Zhang; Jennifer K Smith; David Perez; Terry L Juelich; Igor Morozov; William C Wilson; Alexander N Freiberg; Juergen A Richt
Journal:  PLoS One       Date:  2017-12-21       Impact factor: 3.240

10.  In-vitro and in-vivo study of the interference between Rift Valley fever virus (clone 13) and Sheeppox/Limpy Skin disease viruses.

Authors:  N Safini; Z Bamouh; J Hamdi; M Jazouli; K O Tadlaoui; M El Harrak
Journal:  Sci Rep       Date:  2021-06-11       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.